Racial disparities in survival among patients with germ cell tumors of the ovary—United States

Objective(s)To compare the survival of African American (AA) and white (W) patients with malignant germ cell tumors of the ovary (OGCT).MethodsPatients with a diagnosis of OGCT were identified from Surveillance, Epidemiology, and End Results Program (SEER) from 1988 to 2004, and were divided into African American (AA) and white (W) subgroups. Only surgically treated patients were included. Histology was grouped into dysgerminoma (D), malignant teratoma (MT), and mixed germ cell tumors with pure non-dysgerminoma cell tumors (MGCT/PNDCT). Statistical analysis using Chi-square, Fisher's Exact Test, Kaplan–Meier survival methods, and Cox regression proportional hazards were performed.ResultsIn 1110 patients with OGCT, 970 (87.4%) were W and 140 (12.6%) were AA. MGCT/PNDCT histology was equally represented in AA and W. However, W were twice as likely to present with D (W 34% vs. AA 16%, p < 0.01) and 1.5 times less likely to present with MT (W 41% vs. AA 59%, p < 0.01). The majority (W 64%, AA 64%) of OGCT were stage I. Advanced stage (FIGO III and IV) tumors were more prominent in AA (24% vs. 18%, p > 0.05). Complete surgical staging effort was utilized more frequently in W (49%) as compared to AA (38%; p = 0.001). Overall 5-year survival was 92% for W and 86% for AA (p = 0.02). In multivariate analysis race was not an independent predictor of survival when histology, stage and surgical staging were controlled.Conclusion(s)In our study, a higher prevalence of complete surgical staging and a favorable distribution of low risk histologic types may explain the improved survival observed in white patients with OGCT. However, race was not an independent predictor of survival.